Sarah Cannon Cancer Institute at HealthONE — Denver, Colorado

Sarah Cannon Cancer Institute at HealthONE is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

Sarah Cannon Cancer Institute at HealthONE has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Solid Tumor Malignancies, KRAS G12C Mutation, KRAS G12S Mutation.

Sponsors: Kumquat Biosciences Inc..

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Cancer Institute at HealthONE?

Sarah Cannon Cancer Institute at HealthONE has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Cancer Institute at HealthONE conducted?

Sarah Cannon Cancer Institute at HealthONE has 2 clinical trials on record, with 2 currently active. Their work covers Solid Tumor Malignancies, KRAS G12C Mutation, KRAS G12S Mutation.

Is Sarah Cannon Cancer Institute at HealthONE accredited by Crixeo Health?

Sarah Cannon Cancer Institute at HealthONE has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Cancer Institute at HealthONE?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.